BackLixte Biotechnology Holdings Overview

Lixte Biotechnology Holdings Other Liabilities

Latest other liabilities for LIXT: $0.

Get informed when a big investor buys or sells

+ Follow
Other Liabilities
$0.00

Peer average

Loading

Lixte Biotechnology Holdings Other Liabilities History

Loading

Lixte Biotechnology Holdings vs. peers: Other Liabilities Comparison

Loading

Lixte Biotechnology Holdings Other Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Lixte Biotechnology Holdings (LIXT) FAQ

As of the most recent data (March 2026), LIXT shows a other liabilities of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, LIXT's other liabilities is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Lixte Biotechnology Holdings is outperforming or lagging.

Tracking LIXT's other liabilities over time shows whether Lixte Biotechnology Holdings is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other liabilities page, Stockcircle has Lixte Biotechnology Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other liabilities (currently $0) with ownership activity and broader fundamentals.

Lixte Biotechnology Holdings's other liabilities is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.